HomeSPRY • NASDAQ
add
ARS Pharmaceuticals Inc
Previous close
$11.51
Day range
$11.36 - $12.08
Year range
$2.55 - $16.50
Market cap
1.16B USD
Avg Volume
1.37M
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
In the news
Financials
Income Statement
Revenue
Net income
(USD) | Jun 2024info | Y/Y change |
---|---|---|
Revenue | 500.00K | 4,900.00% |
Operating expense | 15.84M | -23.16% |
Net income | -12.52M | 27.94% |
Net profit margin | -2.50K | 98.56% |
Earnings per share | -0.13 | 27.78% |
EBITDA | -15.32M | 25.56% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
(USD) | Jun 2024info | Y/Y change |
---|---|---|
Cash and short-term investments | 218.74M | -13.27% |
Total assets | 221.97M | -14.22% |
Total liabilities | 6.72M | -34.07% |
Total equity | 215.24M | — |
Shares outstanding | 96.94M | — |
Price to book | 5.18 | — |
Return on assets | -17.06% | — |
Return on capital | -17.45% | — |
Cash Flow
Net change in cash
(USD) | Jun 2024info | Y/Y change |
---|---|---|
Net income | -12.52M | 27.94% |
Cash from operations | -7.28M | 56.33% |
Cash from investing | -12.65M | -128.12% |
Cash from financing | 545.00K | -80.90% |
Net change in cash | -19.38M | -162.21% |
Free cash flow | -2.56M | 75.84% |
About
Founded
2015
Website
Employees
23